Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-08

Clinical Trial Update: Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating sugammadex for reversal of rocuronium after continuous infusion during sevoflurane and propofol anesthesia has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rocuronium (rocuronium bromide)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-02-08